Natasha L. Underwood

Natasha L. Underwood

Auto-generated profile, based on publicly available information

Natasha L. Underwood

Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2019 in Journal of School Health
Verified
Journal Article
Closed access
PDF file
NUNatasha L. Underwood
Natasha L. Underwood
LGLisa Gargano
Lisa Gargano
JSJessica Sales
Jessica Sales
TVTara M. Vogt
Tara M. Vogt
KSKatherine Seib
Katherine Seib
JHJames Hughes
James Hughes

1 February 2016 in Journal of Adolescent Health
Verified
Journal Article
Closed access
KSKatherine Seib
Katherine Seib
NUNatasha L. Underwood
Natasha L. Underwood
LGLisa Gargano
Lisa Gargano
JSJessica M. Sales
Jessica M. Sales
CMChristopher Morfaw
Christopher Morfaw
JHJames M. Hughes
James M. Hughes

1 October 2021 in Drug and Alcohol Dependence
Verified
Journal Article
Open access
NUNatasha Underwood
Natasha Underwood
LCLaura Cremer
Laura Cremer
JCJessica Duncan Cance
Jessica Duncan Cance
JWJason Williams
Jason Williams
GGGery P. Guy
Gery P. Guy
WZWilliam Zule
William Zule
Prescription opioids played a major role in the current opioid overdose epidemic. High rates of opioid prescribing and dispensing exposed many people to opioids, and high-dose opioid prescriptions (e.g., 90 morphine milligram equivalents [MME] per day) contributed to increases in opioid overdoses. The Centers for Disease Control and Prevention (CDC) Prevention for States (PfS) program provided funding to jurisdictions ("PfS recipients") with a high burden of opioid-involved overdoses. This paper examines associations between strategies addressing high-dose opioid prescribing and changes in high-dose opioid dispensing. Monthly opioid dispensing data (2014-2019) from IQVIA Xponent were analyzed using longitudinal growth models (LGM) to compare high-dose opioid dispensing rates in the 29 jurisdictions that participated in PfS with rates in non-PfS jurisdictions. Additional models examined associations between specific PfS activities and changes in high-dose dispensing among PfS recipients. High-dose dispensing rates decreased significantly in both PfS and non-PfS jurisdictions from 2014 to 2019. Rates of high-dose opioid dispensing rates in PfS jurisdictions were not significantly different than those in non-PfS jurisdictions (p = 0.07). Among PfS recipients, multiple activities were associated with decreases in high-dose dispensing rates over time, including moving towards real-time prescription drug monitoring program (PDMP) reporting (p < 0.001) and implementation of opioid dispensing interventions for insurers/ health systems (p < 0.05). High-dose opioid dispensing rates decreased throughout the United States from 2014-2019. As the drug epidemic continues to evolve, implementation of prevention activities by state and local partners is important. These findings highlight two potential prevention strategies and activities that jurisdictions can utilize.

27 August 2022 in Journal of Public Health Management & Practice
Verified
Journal Article
Closed access
NUNatasha L. Underwood
Natasha L. Underwood
HKHeather Kane
Heather Kane
JCJessica Cance
Jessica Cance
KEKyle Emery
Kyle Emery
EEElvira Elek
Elvira Elek
JMJamie Mells
Jamie Mells
Objective: To determine whether any combinations of state-level public health activities were necessary or sufficient to reduce prescription opioid dispensing. Design: We examined 2016-2019 annual progress reports, 2014-2019 national opioid dispensing data (IQVIA), and interview data from states to categorize activities. We used crisp-set Qualitative Comparative Analysis to determine which program activities, individually or in combination, were necessary or sufficient for a better than average decrease in morphine milligram equivalent (MME) per capita. Setting: Twenty-nine US state health departments. Participants: State health departments implementing the Centers for Disease Control and Prevention's Prevention for States (PfS) program. Main Outcome: Combinations of prevention activities related to changes in the rate of prescription opioid MME per capita dispensing from 2014 to 2019. Results: Three combinations were sufficient for greater than average state-level reductions in MME per capita: (1) expanding and improving proactive reporting in combination with enhancing the uptake of evidence-based opioid prescribing guidelines and not moving toward a real-time Prescription Drug Monitoring Program; (2) implementing or improving prescribing interventions for insurers, health systems, or pharmacy benefit managers in combination with enhancing the uptake of evidence-based opioid prescribing guidelines; and (3) not implementing or improving prescribing interventions for insurers, health systems, or pharmacy benefit managers in combination with not enhancing the uptake of evidence-based opioid prescribing guidelines. Interview data suggested that the 3 combinations indicate how state contexts and history with addressing opioid overdose shaped programming and the ability to reduce MME per capita. Conclusions: States successful in reducing opioid dispensing selected activities that built upon existing policies and interventions, which may indicate thoughtful use of resources. To maximize impact in addressing the opioid overdose epidemic, states and agencies may benefit from building on existing policies and interventions.

2 April 2021 in Substance Abuse
Verified
Journal Article
Closed access
NUNatasha Underwood
Natasha Underwood
CRCherie Rooks-Peck
Cherie Rooks-Peck
NANida Ali
Nida Ali
AWApril Wisdom
April Wisdom
OCOlga Costa
Olga Costa
SBSarah Bacon
Sarah Bacon
Background: The Centers for Disease Control and Prevention’s Prevention for States (PfS) program funded 29 state health departments to prevent opioid overdose by implementing evidence-based prevention strategies. The objectives of this analysis were to describe the scope of activities implemented across the four PfS strategies and identify implementation challenges. Methods: PfS recipients submitted annual progress reports (APRs) to state support staff at CDC from 2015 to 2017. APR data were used to calculate the number of required and optional activities implemented under each PfS strategy. APR data were qualitatively analyzed using a systematic content analysis approach to identify key implementation challenges. Results: From 2015 to 2017, PfS recipients implemented 177 activities across four strategies from 2015 to 2017. Cross-cutting implementation challenges were (1) multi-sector collaboration, (2) lack of knowledge and misperceptions about opioid used disorder (OUD) among some partners and local communities and; (3) management and access to opioid data among PfS recipients. Conclusions: PfS recipients implemented an array of prevention interventions to address the opioid overdose crisis and encountered several cross-cutting implementation challenges. Challenges and state driven solutions over the course of implementing PfS led to several lessons learned and actions that CDC enacted to continue to support and expand overdose prevention.

26 February 2022 in Pain Medicine
Verified
Journal Article
Open access
PDF file
NUNatasha L Underwood
Natasha L Underwood
JCJessica Duncan Cance
Jessica Duncan Cance
HKHeather Kane
Heather Kane
CHCaitlin Hennessy
Caitlin Hennessy
ACAleta Christensen
Aleta Christensen
CRCherie Rooks-Peck
Cherie Rooks-Peck
Objective: Academic detailing is a clinical education technique characterized by targeted, one-on-one, interactive conversations between trained staff and the clinician. This study describes variations in implementing academic detailing among jurisdictions receiving funding from the U.S. Centers for Disease Control and Prevention (CDC) to prevent prescription drug overdoses. Design: In 2015, CDC started the Prescription Drug Overdose Prevention for States (PfS) program. Subjects: This study focuses on 11 of the 29 funded jurisdictions that implemented academic detailing as part of their PfS efforts. Methods: Jurisdictions provided annual progress reports from 2016 to 2019. We conducted semistructured interviews in 2017 and 2018 with all funded jurisdictions and conducted follow-up interviews with three jurisdictions in 2020 to obtain additional context. We used an analytic matrix display to identify themes from annual progress report data, the coding report from the 2017/2018 interviews, and the three follow-up interviews from 2020. Results: Two academic detailing models emerged: 1) one-on-one detailing, where centrally trained staff conducted all visits, and 2) a train-the-trainer model. Jurisdictions also described a hybrid model, which they referred to as academic detailing despite not meeting the definition of academic detailing. We identified variations in delivery strategies, staffing, and curriculum development within and between models. Despite these differences, common themes included the need to use data to focus academic detailing and the importance of partnerships. Conclusions: Adoption of academic detailing as a strategy for improving opioid prescribing behaviors has increased. However, there is limited guidance and standardization to guide and evaluate implementation and outcomes.